Project Summary and Objectives:
The project will evaluate the effects of hormone replacement therapy in women with advanced breast cancer in terms of response to tamoxifen and other treatments, progression rates and mortality, menopausal symptoms and quality of life.
Advanced breast cancer has been chosen because effects on disease progression rates can be more rapidly and accurately measured and the ethical problems of giving a potentially harmful treatment are less difficult because of an expected improvement in quality of life.
Further information can be obtained from:
Professor Jack Cuzick
Head of Department
Department of Mathematics, Statistics & Epidemiology
Cancer Research UK
PO Box No 123
Lincoln's Inn Fields
London, WC2A 3PX
|All contents copyright ©
Department of Health. All rights reserved.
Page maintained by Helen Bailey
Last updated 22 November 2004
This page looks best when viewed with either MS Internet Explorer or Netscape Navigator